Be wary if considering stem cell therapy

With stem cell therapy for eye disease being the current trendy news topic, many people are eager to jump the gun and rush into trying it. These therapies are currently being researched and have not been approved by the Food and Drug Administration to be safe and effective. Since there are no stem cell therapies […]

Visual acuity not maintained with anti-VEGF

A follow-up study was conducted to determine the long-term benefit and visual acuity outcomes of patients undergoing anti-VEGF treatments, such as Eyelea, Lucentis and Avastin. What researchers found was that visual gains were not maintained after 5 years of injections. Records of 647 patients with wet AMD were analyzed in the Comparison of Age-Related Macular […]

Cardio drug helpful in treating surfer’s eye

Researchers from Ariel University in Israel recently examined the affect the commonly prescribed cardiovascular drug, dipryidamole, had on┬átreating pterygium, otherwise known as surfer’s eye. Surfer’s eye is┬ácaused by a benign growth of the conjunctiva over the white of the eye. The condition is commonly found in surfers (hence, the name) but is more prevalent in […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]

New genetic links for macular degeneration discovered

A recent study conducted by the University of Pittsburgh revealed 13 new genetic locations on a chromosome linked to macular degeneration. This revelation brings the total known genetic regions to 34. There are many unknown factors surrounding age-related macular degeneration. This discovery of additional genetic links will hopefully allow researchers to develop new therapies that […]

New eye injection method being tested

Medication injections into the eye (intravitreal injections), such as those that are performed for wet macular degeneration, come with a host of possible serious complications such as vitreous hemorrhage, and retinal detachment. A new method of delivery has been developed that involves injections into the suprachoroidal space [see Diagram below] which is between the sclera […]

52 genetic variations of Macular Degeneration identified

Genetics play a much more important role in macular degeneration than previously realized. Scientists looking to find genetic variations responsible for age-related macular degeneration (AMD) successfully identified 52 variations associated with AMD. This discovery will hopefully allow scientists to create diagnostic tools to help identify which patients are at a higher risk of developing AMD […]

Device being developed to treat AMD

A low-level light treatment known as photobiomodulation is being developed by the LumiThera company and could be a non-invasive and effective therapy for treating macular degeneration and diabetic macular edema. Photobiomodulation is already in use to treat chronic pain and accelerate healing from sports injuries and has a great safety record. A trial of 30 […]

When it comes to glaucoma risk, look to your roots

Your chances of developing glaucoma increase if there is a family history of the disease. Unfortunately, glaucoma is a silent disease and most people don’t realize they have it until they notice changes in their vision. A comprehensive dilated eye exam can catch the disease in its early stages. Left untreated, glaucoma can cause vision […]

Taking a “Peek” at the retina with new device

A new device called the Portable Eye Examination Kit (PEEK) Retina is being developed by Peek Vision and it will connect to smartphones and allow doctors to perform complete and affordable eye exams. The Peek Retina works by clipping onto a smartphone camera and they physician is then able to examine the retina. High-quality images […]